Literature DB >> 27270186

Why in 2016 are patients with hypertension not 100% controlled? A call to action.

Josep Redon1, Jean-Jacques Mourad, Roland E Schmieder, Massimo Volpe, Thomas W Weiss.   

Abstract

The objective is to consider the problem of high blood pressure (BP), a leading global risk factor, associated with substantial morbidity and mortality. Despite the availability of treatment guidelines and a wide range of therapies, BP control is suboptimal in many countries. Recent data indicate that only around 40% of patients manage to achieve an adequate level of BP control. A group of international experts in the field of hypertension met in 2008 to consider this problem. The resulting white paper delivered an urgent call to action and identified six key issues for improving BP control. In 2015, a working group of investigators spontaneously undertook an action with the primary aim of considering the current hypertension management situation in Europe, to discuss whether the situation had changed since 2008 and to determine what can be learnt from the projects in other continents, such as the Canadian Hypertension Education Program, which has shown that higher levels of BP control can be achieved across a general population. The working group identified the main challenges affecting the improvement of BP control today and suggests five key actions: identify the BP treatment target of less than 140/90 mmHg for the majority of patients, simplify treatment strategies and encourage pill reduction, decrease therapeutic inertia, improve patient empowerment, and involve healthcare systems and reduce the prevailing focus on drug costs in many healthcare systems. Implementing key actions identified by the working group may help to improve achievement of better BP control across Europe.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27270186     DOI: 10.1097/HJH.0000000000000988

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  15 in total

1.  Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up.

Authors:  F Fici; G Seravalle; N Koylan; I Nalbantgil; N Cagla; Y Korkut; F Quarti-Trevano; W Makel; G Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-05-11

2.  New Opportunities for Monitoring Blood Pressure Control and Awareness in the Population: Insights from 12-Year Editions of the World Hypertension Day.

Authors:  Massimo Volpe; Giuliano Tocci; Claudio Borghi; Gianfranco Parati
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-10-15

3.  European guidelines on lifestyle changes for management of hypertension : Awareness and implementation of recommendations among German and European physicians.

Authors:  J Bolbrinker; L Zaidi Touis; H Gohlke; B Weisser; R Kreutz
Journal:  Herz       Date:  2017-05-22       Impact factor: 1.443

Review 4.  Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control.

Authors:  Massimo Volpe; Caterina Santolamazza; Vittoria Mastromarino; Roberta Coluccia; Allegra Battistoni; Giuliano Tocci
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-06-12

Review 5.  Should All Patients with Resistant Hypertension Receive Spironolactone?

Authors:  Ján Rosa; Tomáš Zelinka; Ondřej Petrák; Branislav Štrauch; Robert Holaj; Jiří Widimský
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

6.  Prevalence and Control of Hypertension in Different Macro-Areas in Italy: Analysis of a Large Database by the General Practice.

Authors:  Giuliano Tocci; Giulio Nati; Claudio Cricelli; Damiano Parretti; Francesco Lapi; Andrea Ferrucci; Claudio Borghi; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-10-08

7.  Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company.

Authors:  Alessandro Biffi; Giovanna Gallo; Fredrick Fernando; Felice Sirico; Maria Grazia Signorello; Michele Messina; Giorge Manole; Nicola Triglione; Massimo Volpe
Journal:  J Hum Hypertens       Date:  2021-03-23       Impact factor: 3.012

Review 8.  How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension.

Authors:  Giuliano Tocci; Giovambattista Desideri; Elisa Roca; Calogero Calcullo; Massimo Crippa; Nicola De Luca; Giovanni Vincenzo Gaudio; Laura Maria Lonati; Leo Orselli; Angelo Scuteri; Vito Vulpis; Benedetto Acone; Augusto Zaninelli
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-12-02

9.  Cross-sectional survey evaluating blood pressure control ACHIEVEment in hypertensive patients treated with multiple anti-hypertensive agents in Belgium and Luxembourg.

Authors:  Marc Leeman; Michèle Dramaix; Bregt Van Nieuwenhuyse; Josse R Thomas
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

10.  Walking and hypertension: greater reductions in subjects with higher baseline systolic blood pressure following six months of guided walking.

Authors:  Simona Mandini; Francesco Conconi; Elisa Mori; Jonathan Myers; Giovanni Grazzi; Gianni Mazzoni
Journal:  PeerJ       Date:  2018-08-30       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.